[Psychosocial care in the post-transplant setting (SFGM-TC)]

Recent advances in hematology have expanded the indications for allogeneic hematopoietic stem cell transplantation and significantly improved patient survival. Nevertheless, this procedure remains associated with substantial medium- and long-term morbidity, encompassing somatic, psychological, and social complications. Allogeneic transplant recipients frequently experience anxiety and depressive symptoms, cognitive impairments, persistent fatigue, and difficulties with social and occupational reintegration, sometimes lasting several years after transplantation. Although international guidelines recommend structured long-term psychosocial follow-up, their implementation remains inconsistent due to organizational constraints, limited human resources, and insufficient coordination between hospital- and community-based care. In this context, the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) conducted a practice harmonization workshop to examine current approaches to identifying psychosocial needs and referring patients to supportive care services in the post-transplant period. A survey of 103 healthcare professionals, primarily working in transplant centers, revealed a progressive decline in the systematic provision of supportive care after transplantation, particularly beyond day +100, as well as limited use of standardized screening tools. Based on these findings and a comprehensive literature review, the working group proposes the implementation of a brief psychosocial screening checklist to be used by the referring hematologist during key follow-up consultations, and on targeted referral to appropriate professionals, such as psychologists and social workers. The proposed pathway positions the hematologist as the primary point of entry, with supportive care professionals acting as mediators toward tailored interventions. Overall, these recommendations aim to improve early identification of psychosocial difficulties, strengthen care coordination, and ultimately enhance the quality of life of allogeneic transplant recipients.